Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 144

1.

The potential impact of immunization campaign budget re-allocation on global eradication of paediatric infectious diseases.

Fitzpatrick T, Bauch CT.

BMC Public Health. 2011 Sep 28;11:739. doi: 10.1186/1471-2458-11-739.

3.

Combinations of Quality and Frequency of Immunization Activities to Stop and Prevent Poliovirus Transmission in the High-Risk Area of Northwest Nigeria.

Duintjer Tebbens RJ, Pallansch MA, Wassilak SG, Cochi SL, Thompson KM.

PLoS One. 2015 Jun 11;10(6):e0130123. doi: 10.1371/journal.pone.0130123. eCollection 2015.

4.

Six challenges in the eradication of infectious diseases.

Klepac P, Funk S, Hollingsworth TD, Metcalf CJ, Hampson K.

Epidemics. 2015 Mar;10:97-101. doi: 10.1016/j.epidem.2014.12.001. Epub 2014 Dec 12.

5.

Intensified Local Resource Mobilization for the Polio Eradication Initiative: The Experience of World Health Organization in Nigeria During 2008-2015.

Yehualashet YG, Horton J, Mkanda P, Vaz RG, Afolabi O, Gashu SG, Banda R, O'Malley H, Nsubuga P.

J Infect Dis. 2016 May 1;213 Suppl 3:S101-7. doi: 10.1093/infdis/jiv535. Epub 2016 Feb 23.

6.

Controlling measles using supplemental immunization activities: a mathematical model to inform optimal policy.

Verguet S, Johri M, Morris SK, Gauvreau CL, Jha P, Jit M.

Vaccine. 2015 Mar 3;33(10):1291-6. doi: 10.1016/j.vaccine.2014.11.050. Epub 2014 Dec 23.

7.

Eradicating polio: how the world's pediatricians can help stop this crippling illness forever.

Orenstein WA; Committee on Infectious Diseases.

Pediatrics. 2015 Jan;135(1):196-202. doi: 10.1542/peds.2014-3163.

8.

Economic considerations for the eradication endgame.

Barrett S.

Philos Trans R Soc Lond B Biol Sci. 2013 Jun 24;368(1623):20120149. doi: 10.1098/rstb.2012.0149. Print 2013 Aug 5.

9.

Integrated package approach in delivering interventions during immunisation campaigns in a complex environment in Papua New Guinea: a case study.

Vince JD, Datta SS, Toikilik S, Lagani W.

Vaccine. 2014 Aug 6;32(36):4614-9. doi: 10.1016/j.vaccine.2014.04.056. Epub 2014 Apr 30. Review.

PMID:
24795224
10.

Can Economic Analysis Contribute to Disease Elimination and Eradication? A Systematic Review.

Sicuri E, Evans DB, Tediosi F.

PLoS One. 2015 Jun 12;10(6):e0130603. doi: 10.1371/journal.pone.0130603. eCollection 2015. Review.

11.

The expanded programme on immunization: a lasting legacy of smallpox eradication.

Okwo-Bele JM, Cherian T.

Vaccine. 2011 Dec 30;29 Suppl 4:D74-9. doi: 10.1016/j.vaccine.2012.01.080. Review.

PMID:
22486980
12.

A new global immunisation vision and strategy.

Bilous J, Eggers R, Gasse F, Jarrett S, Lydon P, Magan A, Okwo-Bele JM, Salama P, Vandelaer J, Villeneuve P, Wolfson L.

Lancet. 2006 May 6;367(9521):1464-6. No abstract available.

PMID:
16679143
13.

"Herd immunity": a rough guide.

Fine P, Eames K, Heymann DL.

Clin Infect Dis. 2011 Apr 1;52(7):911-6. doi: 10.1093/cid/cir007. Review.

PMID:
21427399
14.

Eradicating and eliminating infectious diseases: past, present and future.

Narain JP.

Indian J Public Health. 2011 Apr-Jun;55(2):81-7. doi: 10.4103/0019-557X.85236.

15.
16.

Social contact networks and disease eradicability under voluntary vaccination.

Perisic A, Bauch CT.

PLoS Comput Biol. 2009 Feb;5(2):e1000280. doi: 10.1371/journal.pcbi.1000280. Epub 2009 Feb 6.

17.

Eradicating infectious disease using weakly transmissible vaccines.

Nuismer SL, Althouse BM, May R, Bull JJ, Stromberg SP, Antia R.

Proc Biol Sci. 2016 Oct 26;283(1841). pii: 20161903.

18.

Multiple dose vaccination against childhood diseases: high coverage with the first dose remains crucial for eradication.

Paulo AC, Gomes MC, Casinhas AC, Horta A, Domingos T.

IMA J Math Appl Med Biol. 2000 Sep;17(3):201-12.

PMID:
11103718
19.

Benefit-cost analysis of the national pseudorabies virus eradication program.

Miller GY, Tsai JS, Forster DL.

J Am Vet Med Assoc. 1996 Jan 15;208(2):208-13.

PMID:
8567375
20.

WHO's budgetary allocations and burden of disease: a comparative analysis.

Stuckler D, King L, Robinson H, McKee M.

Lancet. 2008 Nov 1;372(9649):1563-9. doi: 10.1016/S0140-6736(08)61656-6.

PMID:
18984189

Supplemental Content

Support Center